Mylan (NSDQ:MYL) today announced the launch of its Wixela Inhub product, a generic for GlaxoSmithKline‘s (NYSE:GSK) Advair Diskus device, for people with asthma or chronic obstructive pulmonary disease.
The company touted that its device’s list price is 70% less than Advair Diskus and 67% less than GSK’s generic.
Get the full story at our sister site, Drug Delivery Business News.
The post Touting pricetag, Mylan launches Advair generic appeared first on MassDevice.
from MassDevice http://bit.ly/2tj7uTK
Cap comentari:
Publica un comentari a l'entrada